A decade-long study by Harvard scientists suggests that lithium deficiency, triggered by amyloid plaques in the brain, may be a key factor in the early stages of Alzheimer’s disease. By testing innovative lithium compounds that evade plaque capture, researchers were able to reverse memory loss in mice at far lower doses than those used for psychiatric treatments.